Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academics Conferences

"Riding New Waves in Liver Diagnosis, Staging & Treatment"
- Liver 2018

Welcome Message



Allied Academies officially welcomes you to attend the World Liver Conference 2018 which is going to be held in New York, U.S.A during May 25-26, 2018. The main theme of the conference is Riding New Waves in  Liver Diagnosis, Staging& Treatment. This International Liver Conference 2018 gathering will concentrate on the most recent and energizing advancements in every aspect of liver inquire about providing a one of a kind open door for examiners over the globe to meet, organize, and see new logical developments.

The occasion gives the best stage with its efficient logical program to the gathering of people which incorporates symposiums, workshops, keynote addresses, all-hands meetings, Young Researcher Forum, board exchanges and notice sessions on most recent research and innovative improvements in the field and additionally remedial viewpoints.Best notice moderators will be judged and granted amid the gathering. To energize expansive support from everywhere throughout the world, Allied Academies is putting forth diminished enrollment charge for understudies.

    The principle point of this meeting is to assemble Hepatologists,Gastroenterologists, Internists, Physicians, Microbiologists, Virologists,Pathologists, Oncologists, Directors/CEO and Industry specialists, Professors, Researchers, Scientists, Surgeons, Toxicologists, Researchers, Students,Business agents and Young specialists and to give a worldwide discussion to the dispersal of unique research comes about, new thoughts and useful improvement encounters identified with the examination.  

 Extent of the conference-:

This International Liver Meeting 2018 gives an awesome stage byget-together prominent educators, Researchers, Students and representatives totrade new thoughts. World Liver Conference 2018 willconcentrate on bringing together the worldwide facts of Digestive System and Liver, which can yieldimportant research through multidisciplinary association. Together we can bringissues to light over all strengths to help guide and treat our patients;increment our insight on the early cautioning signs; make better direction fortreatment choices, and also give access to a more extensive range ofintelligence/research from a multidisciplinary perspective and the logicalprogram will investigate what is new in diagnostics and therapeuticsmodalities, and unite a more extensive group to network and share learning.

Why to go to the conference?

  • Present your most recent research
  • Find new financing and research openings
  • Construct joint efforts and contacts with universal associates to further proceed with one’s research at the worldwide level
  • Understand the ebb and flow condition of research

  • Engage with editors of the top diaries in your field


Track-1: Liver Transplantation and Liver Surgery (experimental & clinical)

Liver transplantation or hepatic transplantation is the supplanting of an infected liver with a few or the majority of a solid liver from someone else. The most normally utilized strategy is orthotopic transplantation, in which the native liver is evacuated and supplanted by the giver organ in an indistinguishable anatomic area from the original liver. Liver transplantation is a practical treatment alternative for end-stage liver disease and intense liver failure.

Track-2: Molecular and cellular biology

Molecular and Cell Biology of the Liver elements the most recent research discoveries with respect to liver structure and function. This Topic will cover liver biology from the atomic level to group of liver cells and will clarify how groups of hepatocytes collaborate in comparative microenvironments. Other essential cell types found in the liver will also be examined.

Track-3Liver cancer

Liver cancer, otherwise called hepatic cancer and primary hepatic cancer, is cancer that begins in the liver. Cancer which has spread from somewhere else to the liver, known as liver metastasis, is more typical than that which begins in the liver. Symptoms of liver growth may include an irregularity or pain in the right side beneath the rib cage, swelling of the abdomen, yellowish skin, easy bruising, weight loss, and weakness. The leading reason for liver cancer is cirrhosis because of hepatitis B, hepatitis C, or alcohol. Different causes include aflatoxin, non-alcoholic fatty liver disease, and liver flukes. The most widely recognized sorts are hepatocellular carcinoma (HCC), which makes up 80% of cases, and cholangiocarcinoma. Primary liver cancer is all around the 6th most frequent cancer (6%) and the second leading reason for death from cancer (9%). In 2012 it occurred in 782,000 individuals and brought about 746,000 passing. In 2013, 300,000 passing from liver cancer were because of hepatitis B, 343,000 to hepatitis C, and 92,000 to alcohol. Higher rates of liver cancer happen where hepatitis B and C are normal, including Asia and sub-Saharan Africa.

Track-4: Liver Tumors

The most frequent, harmful, primary liver tumor is hepatocellular carcinoma (also named hepatoma, which is a misnomer since adenomas are typically benign). More uncommon essential types of liver cancer include cholangiocarcinoma, mixed tumors, sarcoma and hepatoblastoma; an uncommon harmful tumor in kids.

Track-5: Liver fibrosis

Liver fibrosis is the scarring procedure that represents to the liver's reaction to damage. In the same way as skin and different organs heal wounds through deposition of collagen and other grid constituents so the liver repairs damage through the deposition of new collagen. Over time this process can result in cirrhosis of the liver, in which the architectural organization of the functional units of the liver becomes so disrupted that blood flow through the liver and liver function become disrupted. Once cirrhosis has developed, the serious complications of liver disease may occur, including portal hypertension, liver failure and liver cancer. Cirrhosis and liver cancer are now among the top ten causes of death worldwide, and in many developed countries liver disease is now one of the top 5 causes of death in middle-age.

Track-6: Liver Inflammation and Immunology

Liver inflammation is a response that happens when liver cells are assaulted by a sickness bringing on microorganism or substance. The word hepatitis alludes to liver inflammation. Most types of hepatitis result from viral disease, despite the fact that now and again it is brought on by an immune system issue, in which the body's safe framework assaults liver cells since it can't differentiate between unsafe trespassers and solid liver tissue. Harm to the liver from liquor, toxins, and certain medications can likewise bring about inflammation. Liver Immunology implies the special connection between the liver and the immune system. Livers hose down immunity to such a degree, to the point that they can be transplanted without dismissal sometimes. Livers may be endured, as well as keep the dismissal of other organ unites from a similar benefactor, a procedure known as immune tolerance.

Track-7: Drug Induced Liver Injury (DILI)

Drugs are an important cause of liver damage. More than nine hundred medications, toxins, and herbs have been reported to cause liver damage, and drugs represent twenty to forty percent of all cases of fulminant hepatic failure. Roughly seventy five percent of the idiosyncratic drug reactions result in liver transplantation or death. Drug-induced hepatic injury is the most common reason cited for withdrawal of an approved drug. Knowledge of the commonly implicated agents and a high index of suspicion are essential in diagnosis.

Track-8: Viral Hepatitis C

Hepatitis C is a viral infection that causes liver inflammation and damage. Inflammation is swelling that happens when tissues of the body become harmed or contaminated. Inflammation can harm organs. Infections attack ordinary cells in your body. Numerous viruses cause infections that can be spread from individual to individual. The hepatitis C infection spreads through contact with a contaminated individual's blood. Hepatitis C can cause a acute or chronic infection. Although no vaccine for hepatitis C is available, you can take steps to protect yourself from hepatitis C. If you have hepatitis C, talk with your doctor about treatment. Medicines can cure most cases of hepatitis C.

Track-9: Hepatitis B and Other Viral Hepatitis

"Hepatitis" implies inflammation of the liver. The liver is a fundamental organ that procedures supplements, channels the blood, and battles diseases. At the point when the liver is kindled or harmed, its capacity can be influenced. Substantial liquor utilizes, toxins, a few meds, and certain medicinal conditions can bring about hepatitis. Notwithstanding, hepatitis is regularly brought on by an infection. In the United States, the most widely recognized sorts of viral hepatitis will be Hepatitis A, Hepatitis B and Hepatitis C. Non-viral hepatitis is an inflammation of the liver that can bring about scarring on the liver (cirrhosis), liver cancer, liver disappointment and death. There are 3 sorts of non-viral hepatitis: Toxic hepatitis is brought about by chemicals, drugs (medicine and over-the-counter) and nutritious supplements.

Track-10: Other Liver Diseases

Your liver is the biggest organ inside your body. It helps your body process nourishment, store vitality, and remove poisons. There are numerous sorts of liver infections. Infections cause some of them, similar to hepatitis A, hepatitis B, and hepatitis C. Others can be the consequence of medications, toxic substances or drinking excessively liquor. On the off chance that the liver structures scar tissue as a result of a disease, it's called cirrhosis. Jaundice, or yellowing of the skin, can be one indication of liver infection. Tumor can influence the liver. You could likewise acquire a liver infection, for example, hemochromatosis. Tests, for example, imaging tests and liver capacity tests can check for liver harm and help to analyze liver maladies.

Track-11: Pediatric Hepatology

Hepatology is a branch of gastroenterology, which includes the diagnosis and treatment of issues of the digestive system. A pediatric hepatologist is a gastroenterolgist with further instruction and preparing in treating s of the liver in children. The Division of Pediatric Hepatology offers exhaustive inpatient, outpatient and lab services to assess and treat new born children, kids and young people with gastrointestinal issue, celiac disease and EOE.  In the United States, one out of five children has chronic abdominal pain. 40% of kids are fundamentally overweight or hefty, and 10% experience the ill effects of an inability to flourish.

Track-12: Liver Growth and repair

The liver is the main instinctive organ that has the astounding ability to recover. The liver can recover after either surgical removal or after chemical injury. It is known that as little as 25% of the original liver mass can recover back to its full size. The process of recovery in mammals is essentially compensatory development in light of the fact that lone the mass of the liver is replaced, not the shape. However, in lower species, for example, fish, both liver size and shape can be replaced. Liver recovery includes replication of the liver cells, mainly hepatocytes, followed by other cells such as biliary epithelial cells and sinusoidal endothelial cells. When cell proliferation is finished, the recently isolated cells experience rebuilding, angiogenesis and renewal of extracellular matrix to finish the recovery procedure. Strikingly, much of the time, liver function is only partially affected during liver recovery. While certain particular functions, for example, drug metabolism decrease, many other primary functions such as albumin and bile production are not substantially influenced.

Track-13: HCV/HIV Coinfection

All HIV-infected people with HCV co infection should be screened for other viral hepatitis and immunized against hepatitis A and hepatitis B if that they are not immune. HCV-tainted patients should to be advised cautioned to limit the exposure to hepatotoxins, including liquor, excessive acetaminophen (>2 grams/day), and marijuana, which may add to steatosis and fibrosis. Patients should be guided about decreasing the risk of transmitting HCV to others, which may happen by sharing IDU equipment and having unprotected sex. People with advance fibrosis or cirrhosis ought to be screened for hepatocellular carcinoma every 6-12 months with ultrasound and alpha-fetoprotein (AFP) testing.

Track-14: Liver Imaging modalities

Imaging is basic for precisely diagnosing biliary tract issue and is imperative for identifying central liver injuries (eg, abscess, tumor). It is limited in detecting and diagnosing diffuse hepatocellular malady (eg, hepatitis, cirrhosis).

Market Analysis

Mordor Intelligence experts forecasted the Global Liver Cancer Market is presently esteemed at USD 707 million, according to 2016. Liver growth speaks to the fifth most regularly happening malignancy and the third driving purpose behind passing’s identified with disease on the planet. About 8,00,000 are determined every year to have essential carcinoma.

Worldwide Liver Disease Treatment Market is relied upon to accumulate $19,536 million by 2022, enlisting a CAGR of 11.72% amid the gauge time frame 2016 - 2022. The Liver malady treatment market is guaranteed to develop because of neglected clinical needs and forthcoming treatment changes.

                        Various novel operators have demonstrated enhancements in clinical trials, for example, obeticholic acid, thiazolidinediones and vitamin E for treatment of nonalcoholic greasy liver illnesses. Furthermore, as indicated by American Cancer Society liver disease rates increments 2.7% consistently, moving the development of the market.

Some facts-                                

·         In the U.S. it is evaluated that more than 15 million individuals are included in the manhandle or over mishandle of liquor and among them over 90% individuals experience the ill effects of greasy liver malady.

·         More than 30 million individuals or one of every 10 Americans have some type of liver disease.

·         There are more than 100 types of liver diseases.

·         More than 1 million Americans are infected from hepatitis B and 4 million Americans have hepatitis C. Dissimilar to hepatitis A and hepatitis B, there's no vaccine to prevent hepatitis C.

·         20 percent of Americans is having fatty livers, which is the premise of non-alcoholic fatty liver disease or NAFLD.

·         Every year, around 21 thousand Americans are diagnosed with primary liver cancer which is one of the few cancers on the rise in the U.S.

·         Approximately 15 thousand kids are hospitalized each year in the United States because of pediatric liver disease or disorders.

·         Around Six million kids which is up to 10 percent of all kids in the country is having NAFLD, the non-alcoholic fatty liver disease. NAFLD is the leading cause of chronic liver disease in kids and adults in the U.S.

·         Each year, approximately 15 thousand American die because of liver cancer or chronic liver disease related with viral hepatitis.

·         Currently, around 16 thousand adults and kids are on the national waiting list for liver transplants.

·         Since from January 1, 1988, there were around more than 123,392 liver transplants done in the United States, as per information from UNOS/OPTN. Of those, 4,931 were living donors.

·         But, then again, UNOS/OPTN information uncovers that since from January 1, 1995, more than 29,424 recorded patients died on while still waiting for liver transplants.

Statistics of Liver Cancer by American Cancer Society's (ACS)

  •            In 2017, it is estimated that around 40,710 adults (29,200 men and 11,510 women) in the U.S.A will be diagnosed with primary liver cancer.
  •             And also it is estimated that in year 2017 around 28,920 deaths (19,610 men and 9,310 women) from primary liver cancer will occur.

Organizing Committee
OCM Member
Stanley H. Weiss, MD
Professor of Medicine at Rutgers New Jersey Medical School & Professor of Epidemiology at Rutgers School of Public Health
Rutgers New Jersey Medical School
Newark , USA
OCM Member
Mohamed Abdel Salam El-Guindi
Vice Dean Professor Pediatrics at National Liver Institute Menoufiya University & President Egyptian Society PGHAN
National Liver Institute
Cario, Egypt
OCM Member
Arnolfo Petruzziello
Professor, Virology and Molecular Biology
National Cancer Institute
Naples, Italy
OCM Member
Maxwell Chait
Internal Medicine and Gastroenterology
Columbia University College of Physicians and Surgeons
New York, USA
OCM Member
Mustafa Ates
Department of General Surgery
Inonu University
Nigde, Turkey
OCM Member
Wasim Jafri
President of Pakistan Society for the Study of Liver Diseases, Department of Medicine
Aga Khan University Hospital
Karachi, Pakistan
OCM Member
Hideaki Kawabata
Kyoto Okamoto Memorial Hospital
Kyoto, Japan
OCM Member
Davide Ghinolfi
Hepatobiliary Surgery and Liver Transplantation Unit
Pisana University Hospital
Florence, Italy
OCM Member
Steven Dooley
Heidelberg University
Stuttgart, Germany
OCM Member
Ashwani K. Singal
University of Alabama at Birmingham
Birmingham, USA
Scientific Program
Renowned Speakers

Hilton New York JFK Airport Hotel

144-02 135th Avenue | Jamaica, New York 11436 | USA

Hilda Cangelosi ~ Director of Sales

t: +1 718.269.3041

email -


Join The Discussion

Allied Academies Global Conference Directory

Mail us at

Program enquiry
General Queries
More details about

Terms and Conditions

Terms and conditions

Authorization Policy

terms and policy
Copyright © 2019-2020 Allied Academies, All Rights Reserved.